GoKawiilPsilocybin prevents chemotherapy-induced nerve damage in mouse study
Researchers at MD Anderson Cancer Center found that two doses of psilocybin, the psychoactive compound in magic mushrooms, given before chemotherapy completely prevented mice from developing neuropathy, a painful nerve condition affecting up to 60% of patients on platinum-based cancer drugs. The findings, published in Science, suggest the compound protects sensory nerve endings from the energy depletion that chemotherapy drugs typically cause.
GoKawiil's interpretation of the reporting above, not reported fact.
Chemotherapy-induced neuropathy has no reliable prevention or treatment, leaving many cancer survivors with lasting pain and numbness even after successful treatment. This research expands the potential use of psychedelics beyond mental health conditions like depression and PTSD into physical pain prevention, opening a new avenue for protecting patients during cancer treatment.
- Two psilocybin doses before chemotherapy fully prevented neuropathy in mice
- Neuropathy affects up to 60% of patients on platinum-based chemotherapy drugs
- Study suggests psilocybin protects nerve mitochondria, a new use beyond mental health treatment
Source: nature.com — Kozlov, 2026-09-03
Published there as: “Magic-mushroom compound blocks a severe side effect of chemotherapy, in mice”
Read the original report → The summary and analysis above are GoKawiil's own, written from reporting by the source above. Facts and quotes belong to the original publisher.